BR9917113A - Agente para tratar de distúrbio de função de células visuais compreendendo um inibidor de interleucina 2, seu método de tratamento e uso - Google Patents
Agente para tratar de distúrbio de função de células visuais compreendendo um inibidor de interleucina 2, seu método de tratamento e usoInfo
- Publication number
- BR9917113A BR9917113A BR9917113-9A BR9917113A BR9917113A BR 9917113 A BR9917113 A BR 9917113A BR 9917113 A BR9917113 A BR 9917113A BR 9917113 A BR9917113 A BR 9917113A
- Authority
- BR
- Brazil
- Prior art keywords
- interleukin
- agent
- inhibitor
- treatment
- cell function
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"AGENTE PARA TRATAR DE DISTúRBIO DE FUNçãO DE CéLULAS VISUAIS COMPREENDENDO UM INIBIDOR DE INTERLEUCINA 2, SEU MéTODO DE TRATAMENTO E USO". A presente invenção provê um agente para o tratamento de distúrbio de função de células visuais contendo um inibidor de interleucina, tal como composto de macrolídeo, particularmente FK506.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11393998P | 1998-12-24 | 1998-12-24 | |
PCT/JP1999/007161 WO2000038703A1 (en) | 1998-12-24 | 1999-12-20 | Agent for treating visual cell function disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9917113A true BR9917113A (pt) | 2001-10-23 |
Family
ID=22352417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9917113-9A BR9917113A (pt) | 1998-12-24 | 1999-12-20 | Agente para tratar de distúrbio de função de células visuais compreendendo um inibidor de interleucina 2, seu método de tratamento e uso |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1140134A1 (pt) |
JP (1) | JP2002542150A (pt) |
KR (1) | KR20010099928A (pt) |
CN (1) | CN1224420C (pt) |
AR (1) | AR022017A1 (pt) |
AU (1) | AU781049B2 (pt) |
BR (1) | BR9917113A (pt) |
CA (1) | CA2356382A1 (pt) |
MX (1) | MXPA01006449A (pt) |
NO (1) | NO20013146L (pt) |
NZ (1) | NZ513111A (pt) |
TW (1) | TW546145B (pt) |
WO (1) | WO2000038703A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
AU2003209297A1 (en) | 2002-01-18 | 2003-09-02 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
CA2498191C (en) | 2002-09-18 | 2012-04-10 | Trustees Of The University Of Pennsylvania | Method of inhibiting choroidal neovascularization |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
DK1848431T3 (en) | 2005-02-09 | 2016-04-18 | Santen Pharmaceutical Co Ltd | LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS |
US7592330B2 (en) | 2005-08-08 | 2009-09-22 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
WO2007092620A2 (en) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
KR101520408B1 (ko) | 2006-03-23 | 2015-05-14 | 산텐 세이야꾸 가부시키가이샤 | 혈관 투과성-관련 질환 또는 상태를 위한 제형 및 방법 |
EP3868407A4 (en) * | 2018-10-15 | 2022-02-23 | Osaka University | MEDICINE FOR IMPROVING OR PREVENTING RETINA AND/OR PHOTORECEPTION RELATED SYMPTOMS AND METHOD FOR SCREENING SUBSTANCE FOR IMPROVING OR PREVENTING RETINA AND/OR PHOTORECEPTION RELATED SYMPTOMS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544802B1 (en) * | 1990-08-23 | 1997-01-22 | New York University | Methods and compositions for treating t-cell mediated diseases |
IL102414A (en) * | 1991-07-25 | 1996-08-04 | Univ Louisville Res Found | Medicinal preparations for the treatment of ocular inflammation, containing rapamycin |
US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
US5597809A (en) * | 1994-06-23 | 1997-01-28 | Massachusetts Eye & Ear Infirmary | Treatment of optic neuritis |
US6380261B1 (en) * | 1997-06-30 | 2002-04-30 | Allergan Sales, Inc. | Calcium blockers to treat proliferative vitreoretinopathy |
CZ287497B6 (cs) * | 1997-12-30 | 2000-12-13 | Galena, A. S. | Topické oční přípravky s imunosupresivními látkami |
US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
-
1999
- 1999-12-20 NZ NZ513111A patent/NZ513111A/en unknown
- 1999-12-20 CA CA002356382A patent/CA2356382A1/en not_active Abandoned
- 1999-12-20 JP JP2000590655A patent/JP2002542150A/ja active Pending
- 1999-12-20 EP EP99959930A patent/EP1140134A1/en not_active Withdrawn
- 1999-12-20 BR BR9917113-9A patent/BR9917113A/pt not_active IP Right Cessation
- 1999-12-20 MX MXPA01006449A patent/MXPA01006449A/es unknown
- 1999-12-20 WO PCT/JP1999/007161 patent/WO2000038703A1/en not_active Application Discontinuation
- 1999-12-20 CN CNB998162760A patent/CN1224420C/zh not_active Expired - Fee Related
- 1999-12-20 KR KR1020017008060A patent/KR20010099928A/ko not_active Application Discontinuation
- 1999-12-20 AU AU16906/00A patent/AU781049B2/en not_active Ceased
- 1999-12-22 TW TW088122634A patent/TW546145B/zh not_active IP Right Cessation
- 1999-12-23 AR ARP990106748A patent/AR022017A1/es not_active Application Discontinuation
-
2001
- 2001-06-22 NO NO20013146A patent/NO20013146L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000038703A1 (en) | 2000-07-06 |
AU781049B2 (en) | 2005-05-05 |
CA2356382A1 (en) | 2000-07-06 |
TW546145B (en) | 2003-08-11 |
NZ513111A (en) | 2003-10-31 |
EP1140134A1 (en) | 2001-10-10 |
AU1690600A (en) | 2000-07-31 |
CN1352565A (zh) | 2002-06-05 |
NO20013146L (no) | 2001-08-20 |
MXPA01006449A (es) | 2002-04-24 |
KR20010099928A (ko) | 2001-11-09 |
JP2002542150A (ja) | 2002-12-10 |
CN1224420C (zh) | 2005-10-26 |
AR022017A1 (es) | 2002-09-04 |
NO20013146D0 (no) | 2001-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0011225A (pt) | Agente para tratar de olhos secos, seu método e uso | |
CA2222303A1 (fr) | Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles | |
PT918504E (pt) | Utilizacao da genisteina como agente preventivo contra a fotolesao e o cancro cutaneos induzidos pela radiacao ultravioleta | |
AU2713500A (en) | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia | |
FI973492A (fi) | NO-syntaasin estäjät | |
NZ517616A (en) | Use of retigabin for treating neuropathic pain | |
DE69533697D1 (de) | ANTISENSE OLIGONUKLEOTIDMODULATION DER raf GENEXPRESSION | |
MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
BR9812122A (pt) | Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata | |
UA39189C2 (uk) | Бактерицидний засіб, спосіб боротьби з грибковими хворобами рослин та захисту рослин від ураження грибками | |
ES2192832T3 (es) | Uso de compuestos macrolidos para tratar glaucoma. | |
MX9306295A (es) | Composiciones farmaceuticas para tratar sintomas de resfriado. | |
MY123201A (en) | Plant-activating agent | |
BR9507730A (pt) | Uso de formulações em gel como composições de tratamento | |
GR3031917T3 (en) | Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors | |
BR9917113A (pt) | Agente para tratar de distúrbio de função de células visuais compreendendo um inibidor de interleucina 2, seu método de tratamento e uso | |
WO1997004788A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
BR9808221A (pt) | Método de tratamento de tumor. | |
WO2001006990A3 (en) | Use of etodolac to treat cancer | |
MXPA03011270A (es) | Uso de antagonistas rank para tratar cancer. | |
PL349309A1 (en) | Creatine fibre protecting composition, method of protecting creatine fibre and treatment set for chemically treating creatine fibre | |
AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. | |
EE04711B1 (et) | Antiseptiline kompositsioon, puidust või muust materjalist põhimiku töötlemismeetod, puidu või muu materjali kaitsmismeetod, oksatiasiini ühendi, pluss ühe või mitme kvaternaarse ammooniumiühendi ja triasooliühendi kasutamine | |
PT90085A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica | |
DE69716056D1 (de) | Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Free format text: SUCAMPO AG (CH) |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 8A. E 9A. ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DE RPI 1999 DE 28/04/2009. |